27.67 +0.32 (1.19%)
After hours: 4:11PM EDT
|Bid||26.00 x 1800|
|Ask||27.29 x 1800|
|Day's Range||27.22 - 28.58|
|52 Week Range||27.02 - 50.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||32.60|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||40.67|
The Portland, Maine-based company said it had a loss of 14 cents per share. Earnings, adjusted for non-recurring costs, were 14 cents per share. The results fell short of Wall Street expectations. The ...
The launch of Covetrus creates a new global market leader in technology and services in animal health to drive new health and financial outcomes for veterinarians and their.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
The final winners are selected by the NEVYs Technology, Healthcare and Life Sciences Academies among a pool of nominees revealed in March. This year's seventh annual NEVYs marked the first time the Healthcare category had a dedicated Academy distinct from Life Sciences.
The rescheduled date will provide the Company, together with its independent accounting firm and transaction legal and financial advisors, with more time to complete and review the financial statement consolidation in order to file the first quarter 2019 10-Q simultaneously with the first quarter 2019 earnings release, which the Company believes is best practice. Importantly, this additional time does not relate to the Company’s business operations or the accounting for those operations but is a reflection solely of the complexities of the transaction and intra-quarter close of the carve-out of the Animal Health Business from Henry Schein and the subsequent merger with Vets First Choice.
Covetrus (CVET), a global leader in animal-health technology and services, today announced a new partnership with Mars Petcare that will help U.S.-based veterinarians enhance dental health and medication compliance for their pet owner clients. As of May 1, veterinarians can now purchase Mars Petcare’s GREENIES products for their in-clinic and online channels exclusively from Covetrus. The partnership includes the popular and widely-used GREENIES Dental Treats and the simple-to-use GREENIES™ PILL POCKETS™, a proven solution to make medicating pets easier.
Covetrus (CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2019 results after the market closes on Thursday, May 9, 2019. Following the release, the company will hold a conference call at 4:45 PM Eastern Time, during which Benjamin Shaw, president and chief executive officer, and Christine T. Komola, executive vice president and chief financial officer, will review the first quarter financial results. To access the live webcast of the conference call and the corresponding slide presentation, individuals can visit the Investor Relations page on the Covetrus website, https://www.covetrus.com/investors/events-and-presentations.
Covetrus (CVET), a global leader in animal-health technology and services, announced today that Matthew Leonard has been named Executive Vice President, President North America and Global Supply Chain Officer effective April 8, 2019. In his role, Leonard will lead the North American customer operations business in Dublin, Ohio and be responsible for leading the company’s global manufacturer relationships.